GlassScriptPhysician profile
Mabelle Cohen
NPI 1770661167
$6,762.72
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $403 · 2020: $4,583 · 2021: $75.80 · 2022: $1,590 · 2023: $42.42 · 2024: $68.96.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $111.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $111.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Artivion, INC. | $3,158.22 | 2020-2022 | |
| Angiodynamics, INC. | $1,742.95 | 2019-2020 | |
| Abiomed | $799.91 | 2022 | |
| Atricure, INC. | $306.50 | 2019-2024 | |
| Abbott Laboratories | $217.68 | 2022 | |
| Edwards Lifesciences Corporation | $171.29 | 2019 | |
| Medtronic Vascular, INC. | $139.06 | 2019-2020 | |
| Livanova USA, INC. | $57.62 | 2020 | |
| Medtronic, INC. | $56.55 | 2023-2024 | Corevalve Evolut R |
| Veran Medical Technologies, INC. | $40.10 | 2019 | |
| Lsi Solutions INC | $36.90 | 2021 | |
| Intuitive Surgical, INC. | $22.50 | 2021 | |
| Terumo Cardiovascular Systems Corporation | $13.44 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mabelle Cohen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.